6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
1m ago	TDG Gold Appoints Paul Geddes as Senior Vice-President Business Development and Strategy
1m ago	Meryllion Resources Announces New Non-Brokered LIFE Financing
1m ago	Mkango Resources Announces Opening of Hypromag Plant in Pforzheim
1m ago	Aurania Resources Enters into Agreement with St-Georges to Jointly Advance the Thor Epithermal Gold Project in Iceland
2m ago	Eskay Mining Establishes Rapid Turnaround Analytical Laboratory in Stewart, BC to Accelerate Gold Discovery using detectORE(TM) Technology

About

Maze Therapeutics, Inc. Common Stock (NASDAQ:MAZE) — investor relations, events, news, and company updates on 6ix.

Latest News

Maze Therapeutics Announces $150 Million Registered Offering

Maze Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Highlights

Maze Therapeutics Announces Positive Topline Data from Phase 2 HORIZON Trial of MZE829 Demonstrating the First Clinical Proof-of-Concept in Patients with Broad APOL1-Mediated Kidney Disease

Maze Therapeutics to Participate in the TD Cowen 46th Annual Health Care Conference

Maze Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026

Financials

Revenue

$0

Market Cap

$1.39 B

EPS

-3.05

Community Chat

Ask AI